Works by Deuschle, Christian
Results: 40
FerryCalin: an Engineered Lipocalin Protein Directed against the Transferrin Receptor with Potential for Brain Drug Delivery.
- Published in:
- ChemBioChem, 2023, v. 24, n. 10, p. 1, doi. 10.1002/cbic.202200795
- By:
- Publication type:
- Article
Cerebrospinal fluid fatty acids in glucocerebrosidase-associated Parkinson's disease.
- Published in:
- Movement Disorders, 2012, v. 27, n. 2, p. 288, doi. 10.1002/mds.23984
- By:
- Publication type:
- Article
Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease.
- Published in:
- Frontiers in Aging Neuroscience, 2018, p. 1, doi. 10.3389/fnagi.2018.00051
- By:
- Publication type:
- Article
The longevity gene Klotho and its cerebrospinal fluid protein profiles as a modifier for Parkinson´s disease.
- Published in:
- European Journal of Neurology, 2021, v. 28, n. 5, p. 1557, doi. 10.1111/ene.14733
- By:
- Publication type:
- Article
Linking the phenotype of SNCA Triplication with PET-MRI imaging pattern and alpha-synuclein CSF seeding.
- Published in:
- NPJ Parkinson's Disease, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41531-022-00379-8
- By:
- Publication type:
- Article
Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0150552
- By:
- Publication type:
- Article
GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia.
- Published in:
- PLoS ONE, 2016, v. 11, n. 3, p. 1, doi. 10.1371/journal.pone.0149349
- By:
- Publication type:
- Article
Naturally Occurring Alpha-Synuclein Autoantibodies in Parkinson’s Disease: Sources of (Error) Variance in Biomarker Assays.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0114566
- By:
- Publication type:
- Article
Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease.
- Published in:
- Annals of Neurology, 2021, v. 90, n. 3, p. E1, doi. 10.1002/ana.26128
- By:
- Publication type:
- Article
Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Higher Frequencies of T-Cells Expressing NK-Cell Markers and Chemokine Receptors in Parkinson’s Disease.
- Published in:
- Journal of Ageing & Longevity, 2023, v. 3, n. 1, p. 1, doi. 10.3390/jal3010001
- By:
- Publication type:
- Article
Mitochondrial damage-associated inflammation highlights biomarkers in PRKN/PINK1 parkinsonism.
- Published in:
- 2020
- By:
- Publication type:
- journal article
In vivo markers of Parkinson's disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Anticalin-Proteine als neue Wirkstoffklasse: Für therapeutische Anwendungen.
- Published in:
- Pharmazeutische Industrie (Pharmind), 2020, v. 82, n. 2, p. 283
- By:
- Publication type:
- Article
Longitudinal cognitive decline characterizes the profile of non-PD-manifest GBA1 mutation carriers.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-024-00706-1
- By:
- Publication type:
- Article
CSF α-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson's disease.
- Published in:
- NPJ Parkinson's Disease, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41531-023-00627-5
- By:
- Publication type:
- Article
Inflammatory CSF profiles and longitudinal development of cognitive decline in sporadic and GBA-associated PD.
- Published in:
- NPJ Parkinson's Disease, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41531-023-00476-2
- By:
- Publication type:
- Article
Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson's disease and dementia with Lewy bodies.
- Published in:
- Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01276-6
- By:
- Publication type:
- Article
Seroprevalence of autoimmune antibodies in degenerative ataxias: a broad, disease-controlled screening in 456 subjects.
- Published in:
- Journal of Neurology, 2023, v. 270, n. 11, p. 5649, doi. 10.1007/s00415-023-11900-1
- By:
- Publication type:
- Article
CSF and Serum Levels of Inflammatory Markers in PD: Sparse Correlation, Sex Differences and Association With Neurodegenerative Biomarkers.
- Published in:
- Frontiers in Neurology, 2022, v. 13, p. 1, doi. 10.3389/fneur.2022.834580
- By:
- Publication type:
- Article
Association of elevated cerebrospinal fluid levels of the longevity protein α‐Klotho with a delayed onset of cognitive impairment in Parkinson's disease patients.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 10, p. 1, doi. 10.1111/ene.16388
- By:
- Publication type:
- Article
Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring.
- Published in:
- Frontiers in Human Neuroscience, 2018, p. 1, doi. 10.3389/fnhum.2018.00226
- By:
- Publication type:
- Article
A combined miRNA–piRNA signature to detect Alzheimer's disease.
- Published in:
- Translational Psychiatry, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41398-019-0579-2
- By:
- Publication type:
- Article
Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches.
- Published in:
- Clinical Chemistry & Laboratory Medicine, 2019, v. 57, n. 10, p. 1556, doi. 10.1515/cclm-2019-0015
- By:
- Publication type:
- Article
Structural differences between the ectodomains of murine and human CD98hc.
- Published in:
- Proteins, 2019, v. 87, n. 8, p. 693, doi. 10.1002/prot.25686
- By:
- Publication type:
- Article
A SERUM-BASED BIOMARKER SCORE FOR THE EARLY DIAGNOSIS OF COGNITIVE DECLINE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, p. P1152, doi. 10.1016/j.jalz.2016.07.054
- By:
- Publication type:
- Article
Validating Alzheimer's disease micro RNAs using next-generation sequencing.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2016, v. 12, n. 5, p. 565, doi. 10.1016/j.jalz.2015.12.012
- By:
- Publication type:
- Article
α‐Synuclein in Plasma‐Derived Extracellular Vesicles Is a Potential Biomarker of Parkinson's Disease.
- Published in:
- Movement Disorders, 2021, v. 36, n. 11, p. 2508, doi. 10.1002/mds.28639
- By:
- Publication type:
- Article
The Mutation Matters: CSF Profiles of GCase, Sphingolipids, α‐Synuclein in PD<sub>GBA</sub>.
- Published in:
- Movement Disorders, 2021, v. 36, n. 5, p. 1216, doi. 10.1002/mds.28472
- By:
- Publication type:
- Article
CSF NFL in a Longitudinally Assessed PD Cohort: Age Effects and Cognitive Trajectories.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Intraindividual Neurofilament Dynamics in Serum Mark the Conversion to Sporadic Parkinson's Disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Parkinson's Disease: Glucocerebrosidase 1 Mutation Severity Is Associated with CSF Alpha-Synuclein Profiles.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Dementia with lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Cognitive impairment in Glucocerebrosidase (GBA)‐associated PD: Not primarily associated with cerebrospinal fluid Abeta and Tau profiles.
- Published in:
- Movement Disorders, 2017, v. 32, n. 12, p. 1780, doi. 10.1002/mds.27199
- By:
- Publication type:
- Article
Common diseases alter the physiological age-related blood microRNA profile.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-19665-1
- By:
- Publication type:
- Article
Comparable Autoantibody Serum Levels against Amyloid- and Inflammation-Associated Proteins in Parkinson’s Disease Patients and Controls.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0088604
- By:
- Publication type:
- Article
Plasma Ceramide and Glucosylceramide Metabolism Is Altered in Sporadic Parkinson's Disease and Associated with Cognitive Impairment: A Pilot Study.
- Published in:
- PLoS ONE, 2013, v. 8, n. 9, p. 1, doi. 10.1371/journal.pone.0073094
- By:
- Publication type:
- Article
Serum and Cerebrospinal Fluid Levels of Transthyretin in Lewy Body Disorders with and without Dementia.
- Published in:
- PLoS ONE, 2012, v. 7, n. 10, p. 1, doi. 10.1371/journal.pone.0048042
- By:
- Publication type:
- Article
Design of a surrogate Anticalin protein directed against CD98hc for preclinical studies in mice.
- Published in:
- Protein Science: A Publication of the Protein Society, 2020, v. 29, n. 8, p. 1774, doi. 10.1002/pro.3894
- By:
- Publication type:
- Article
Cerebrospinal Fluid Progranulin, but Not Serum Progranulin, Is Reduced in GRN-Negative Frontotemporal Dementia.
- Published in:
- Neurodegenerative Diseases, 2017, v. 17, n. 2/3, p. 83, doi. 10.1159/000448896
- By:
- Publication type:
- Article